The healthcare spending and pharma sales discussed are for five key groups of markets which are the US, the top five European markets (France, Germany, Italy, Spain, and the UK), Japan, BRIC MT (Brazil, Russia, India, China, Mexico, and Turkey), and the secondary emerging markets (Colombia, Indonesia, Malaysia, Nigeria, the Philippines, Poland, Saudi Arabia, South Africa, Thailand, and Vietnam).
Read More